The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Butyrate Suppression of Colonocyte NF-κB Activation and Cellular Proteasome Activity
Open accessAbstract
Butyrate is derived from the microbial metabolism of dietary fiber in the colon where it plays an important role in linking colonocyte turnover and differentiation to luminal content. In addition, butyrate appears to have both anti-inflammatory and cancer chemopreventive activities. Using confocal microscopy and cell fractionation studies, butyrate pretreatment of a human colon cell line (HT-29 cells) inhibited the tumor necrosis factor-alpha (TNF-alpha)-induced nuclear translocation of the proinflammatory transcription factor NF-kappaB. Butyrate inhibited NF-kappaB DNA binding within 30 min of TNF-alpha stimulation, consistent with an inhibition of nuclear translocation. IkappaB.NF-kappaB complexes extracted from butyrate-treated cells were relatively resistant to in vitro dissociation by deoxycholate, suggesting a change in cellular IkappaB composition. Butyrate treatment increased p100 expression, an IkappaB that was not degraded upon TNF-alpha treatment. Butyrate also reduced the extent of TNF-alpha-induced IkappaB-alpha degradation and enhanced the presence of ubiquitin-conjugated IkappaB-alpha. The suppression of IkappaB-alpha degradation corresponded with a reduction in cellular proteasome activity as determined by in vitro proteasome assays and the increased presence of ubiquitin-conjugated proteins. The butyrate suppression of IkappaB-alpha degradation and proteasome activity may derive from its ability to inhibit histone deacetylases since the specific deacetylase inhibitor trichostatin A had similar effects. These results suggest a potential mechanism for the anti-inflammatory activity of butyrate and demonstrate the interplay between short chain fatty acids and cellular proteasome activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Schwartz, B., Avivi-Green, C., & Polak‐Charcon, S. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006831330340 · Cited by 63
RetractedRegulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
β-catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,529
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
IκB: a Specific Inhibitor of the NF-κB Transcription Factor
Baeuerle, P. A., & Baltimore, D. (1988) · Science · doi:10.1126/science.3140380 · Cited by 2,155
Proteasome inhibitors: valuable new tools for cell biologists.
Lee, D. H., & Goldberg, A. L. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01346-4 · Cited by 1,474
Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease
Segain, J.-P., de la Blétière, D. R., Bourreille, A., Leray, V, Gervois, N., Rosales, C., Ferrier, L., Bonnet, C., Blottière, H. M., & Galmiche, J.-P. (2000) · Gut · doi:10.1136/gut.47.3.397 · Cited by 1,321
Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity
Meng, L., Mohan, R., Kwok, B. H. B., Elofsson, M., Sin, N., & Crews, C. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10403 · Cited by 920
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage
Liu, L., Scolnick, D. M., Trievel, R. C., Zhang, H. B., Marmorstein, R., Halazonetis, T. D., & Berger, S. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1202 · Cited by 776
Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis
Scheppach, W., Sommer, H., Kirchner, T., Paganelli, G.-M., Bartram, P., Christl, S., Richter, F., Dusel, G., & Kasper, H. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91094-k · Cited by 741
Regulation of activity of the transcription factor GATA-1 by acetylation
Boyes, J., Byfield, P., Nakatani, Y., & Ogryzko, V. (1998) · Nature · doi:10.1038/25166 · Cited by 694
The effect of sodium butyrate on histone modification
Sealy, L. (1978) · Cell · doi:10.1016/0092-8674(78)90306-9 · Cited by 686
In vivo ubiquitination and proteasome-mediated degradation of p53(1).
Maki, C. G., Huibregtse, J. M., & Howley, P. M. (1996) · PubMed · Cited by 645
Hague, A., Manning, A. M., Hanlon, K. A., Hart, D., Paraskeva, C., & Huschtscha, L. I. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550329 · Cited by 530
A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB.
Baeuerle, P. A., & Baltimore, D. (1989) · Genes & Development · doi:10.1101/gad.3.11.1689 · Cited by 505
Inan, M. S., Rasoulpour, R. J., Yin, L., Hubbard, A. K., Rosenberg, D. W., & Giardina, C. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70142-9 · Cited by 499
Self-citationSuppression of histone deacetylation in vivo and in vitro by sodium butyrate.
Boffa, L. C., Vidali, G., Mann, R. S., & Allfrey, V. G. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34804-4 · Cited by 478
p53-dependent Induction of Apoptosis by Proteasome Inhibitors
Lopes, U. G., Erhardt, P., Yao, R., & Cooper, G. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.12893 · Cited by 467
Baeuerle, P. A. (1998) · Cell · doi:10.1016/s0092-8674(00)81694-3 · Cited by 438
Nakano, K., Mizuno, T., Sowa, Y., Orita, T., Yoshino, T., Okuyama, Y., Fujita, T., Ohtani-Fujita, N., Matsukawa, Y., Tokino, T., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22199 · Cited by 395
Roles of ubiquitin-mediated proteolysis in cell cycle control
Hershko, A. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80079-8 · Cited by 349
Role of short-chain fatty acids in the prevention of colorectal cancer
Scheppach, W., Bartram, H. P., & Richter, F. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00165-f · Cited by 349
Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts
Gerondakis, S., Grossmann, M., Nakamura, Y., Pohl, T., & Grumont, R. (1999) · Oncogene · doi:10.1038/sj.onc.1203236 · Cited by 329
Michalek, M. T., Grant, E. P., Gramm, C., Goldberg, A. L., & Rock, K. L. (1993) · Nature · doi:10.1038/363552a0 · Cited by 321
Binder, H. J., & Mehta, P. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)91614-4 · Cited by 298
The ubiquitin-mediated proteolytic pathway: Mode of action and clinical implications
Ciechanover, A., Orian, A., & Schwartz, A. L. (2000) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(2000)77:34+<40::aid-jcb9>3.0.co;2-6 · Cited by 282
Rel/NF-kappaB/IkappaB proteins and cancer.
Gilmore, T. D., Koedood, M., Piffat, K. A., & White, D. W. (1996) · PubMed · Cited by 274
Rationale for the luminal provision of butyrate in intestinal diseases
Wächtershäuser, A., & Stein, J. (2000) · European Journal of Nutrition · doi:10.1007/s003940070020 · Cited by 258
Butyrate and the Colonocyte: Production, Absorption, Metabolism, and Therapeutic Implications
Velázquez, O. C., Lederer, H. M., & Rombeau, J. L. (1997) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-5967-2_14 · Cited by 258
Proteasome Inhibition: a New Strategy in Cancer Treatment
Adams, J., Palombella, V. J., & Elliott, P. J. (2000) · Investigational New Drugs · doi:10.1023/a:1006321828515 · Cited by 248
Apoptosis induction resulting from proteasome inhibition
SHINOHARA, K., TOMIOKA, M., NAKANO, H., TONÉ, S., ITO, H., & KAWASHIMA, S. (1996) · Biochemical Journal · doi:10.1042/bj3170385 · Cited by 244
Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis.
Chapman, M. A., Grahn, M. F., Boyle, M. A., Hutton, M., Rogers, J., & Williams, N. S. (1994) · Gut · doi:10.1136/gut.35.1.73 · Cited by 242
Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones
Ullrich, O., Reinheckel, T., Sitte, N., Hass, R., Grune, T., & Davies, K. J. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6223 · Cited by 229
The ubiquitin-proteasome pathway in cancer
Spataro, V, Norbury, C., & Harris, A. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.71 · Cited by 215
Hatakeyama, S., Kitagawa, M., Nakayama, K., Shirane, M., Matsumoto, M., Hattori, K., Higashi, H., Nakano, H., Okumura, K., Onoé, K., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3859 · Cited by 202
Williams, A., Sun, X., Fischer, J. E., & Hasselgren, P.-O. (1999) · Surgery · doi:10.1016/s0039-6060(99)70131-5 · Cited by 196
Evidence for altered regulation of I kappa B α degradation in human colonic epithelial cells
Jobin, C., Haskill, S., Mayer, L., Panja, A., & Sartor, R. B. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.1.226 · Cited by 191
Krappmann, D., Wulczyn, F. G., & Scheidereit, C. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01061.x · Cited by 190
Phillips, J. B., Williams, A. J., Adams, J., Elliott, P. J., & Tortella, F. C. (2000) · Stroke · doi:10.1161/01.str.31.7.1686 · Cited by 182
Boffa, L. C., Lupton, J. R., Mariani, M. R., Ceppi, M., Newmark, H. L., Scalmati, A., & Lipkin, M. (1992) · PubMed · Cited by 175
Salomon, D., Sacco, P. A., Roy, S. G., Simcha, I., Johnson, K. R., Wheelock, M. J., & Ben‐Ze'ev, A. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.5.1325 · Cited by 174
Jacobs, L. R., & Lupton, J. R. (1986) · PubMed · Cited by 171
Proteolysis: The proteasome: a protein-degrading organelle?
Rubin, D. M., & Finley, D. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00172-2 · Cited by 163
Butyrate and the colonocyte: Implications for neoplasia
Velazquez, O. C., Lederer, H. M., & Rombeau, J. L. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02213129 · Cited by 153
Control of gene expression by proteolysis
Pahl, H. L., & Baeuerle, P. A. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80007-x · Cited by 149
Howard, M. D., & Gordon, D. T. (1995) · Journal of Nutrition · doi:10.1093/jn/125.10.2604 · Cited by 135
Hague, A., Butt, A. J., & Paraskeva, C. (1996) · Proceedings of The Nutrition Society · doi:10.1079/pns19960090 · Cited by 132
Effect of organic acid absorption on bicarbonate transport in rat colon
Umesaki, Y., Yajima, T., Yokokura, T., & Mutai, M. (1979) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00622903 · Cited by 123
The ubiquitin-mediated proteolytic pathway as a therapeutic area
Rolfe, M., Chiu, M. I., & Pagano, M. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050081 · Cited by 120
Novel IκBα Proteolytic Pathway in WEHI231 Immature B Cells
Miyamoto, S., Seufzer, B. J., & Shumway, S. D. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.19 · Cited by 119
Regulation of NF-κB activity by IκB-related proteins in adenocarcinoma cells
Dejardin, E., Deregowski, V., Chapelier, M., Jacobs, N., GIELEN, J. E., Merville, M., & Bours, V. (1999) · Oncogene · doi:10.1038/sj.onc.1202599 · Cited by 110
Avivi-Green, C., Polak‐Charcon, S., Madar, Z., & Schwartz, B. (2001) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504001108747558 · Cited by 104
Fiber-derived butyrate and the prevention of colon cancer
Hassig, C. A., Tong, J. K., & Schreiber, S. L. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90111-3 · Cited by 87
Butyrate, aspirin and colorectal cancer
Csordás, A. (1996) · European Journal of Cancer Prevention · doi:10.1097/00008469-199608000-00002 · Cited by 81
Schwartz, B., Avivi-Green, C., & Polak‐Charcon, S. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5763-0_3 · Cited by 80
Easwaran, V., Song, V., Polakis, P. G., & Byers, S. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16641 · Cited by 80
Chakravortty, D., Koide, N., Kato, Y., Sugiyama, T., Mu, M. M., Yoshida, T., & Yokochi, T. (2000) · Journal of Endotoxin Research · doi:10.1177/09680519000060030501 · Cited by 76
Modulation of mucosal cell proliferation in the intestine of rats fed a wheat bran diet
Jacobs, L. R., & White, F. A. (1983) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/37.6.945 · Cited by 74
Giardina, C. A., & Inan, M. S. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(97)00140-7 · Cited by 68
Self-citationRegulation of c‐myc expression by sodium butyrate in the colon carcinoma cell line Caco‐2
Souleimani, A., & Asselin, C. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81758-r · Cited by 67
Butyrate metabolism in the terminal ileal mucosa of patients with ulcerative colitis
Chapman, M., Grahn, M. F., Hutton, M. R. E., & Williams, N. S. (1995) · British journal of surgery · doi:10.1002/bjs.1800820115 · Cited by 66
Lactacystin, a Proteasome Inhibitor : Discovery and its Application in Cell Biology
Tomoda, H., & Ōmura, S. (2000) · YAKUGAKU ZASSHI · doi:10.1248/yakushi1947.120.10_935 · Cited by 61
Barshishat, M., Polak‐Charcon, S., & Schwartz, B. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0899 · Cited by 51
Kanauchi, O., Iwanaga, T., Mitsuyama, K., Saiki, T., Tsuruta, O., Noguchi, K., & Toyonaga, A. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01971.x · Cited by 46
Effect of dietary fiber on colonic cell proliferation and its relationship to colon carcinogenesis
Jacobs, L. R. (1987) · Preventive Medicine · doi:10.1016/0091-7435(87)90073-9 · Cited by 41
Luciano, L., Hass, R., Busche, R., Engelhardt, W. V., & Reale, E. (1996) · Cell and Tissue Research · doi:10.1007/s004410050677 · Cited by 40
Compher, C. W., Frankel, W. L., Tazelaar, J., Lawson, J. A., McKinney, S., Segall, S., Kinosian, B. P., Williams, N. N., & Rombeau, J. L. (1999) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607199023005269 · Cited by 39
Benard, O., & Balasubramanian, K. A. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006892929652 · Cited by 35
Protein kinase C–dependent activation of NF-κB in enterocytes is independent of IκB degradation
Wilson, L. K., Szabó, C., & Salzman, A. L. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70556-1 · Cited by 34
Maintaining gut homeostasis: The butyrate–NF-κB connection
Hodin, R. A. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70150-8 · Cited by 32
Whiteley, L. O., & Klurfeld, D. M. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc3602_1 · Cited by 25
Inhibitory effect of microfibril wheat bran on azoxymethane-induced colon carcinogenesis in CF1 mice
Takahashi, T., Satou, M., Watanabe, N., Sakaitani, Y., Takagi, A., Uchida, K., Ikeda, M., Moriyama-Ebina, R., Matsumoto, K., & Morotomi, M. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00096-8 · Cited by 15
Enhanced apoptosis in transformed human lung fibroblasts after exposure to sodium butyrate
Thomas, G. L., Henley, A., Rowland, T. C., Sahai, A., Griffin, M., & Birckbichler, P. J. (1996) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02723054 · Cited by 13
The proteasome: a molecular target for cancer therapy
Hallahan, D. E., & Teng, M. F. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00517-4 · Cited by 6
Crinelli, R., Bianchi, M., Gentilini, L. S., Magnani, M., & Hiscott, J. B. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00485.x · Cited by 5
Edmonds, C. J. (1982) · Philosophical transactions of the Royal Society of London. Series B, Biological sciences · doi:10.1098/rstb.1982.0153 · Cited by 5
Cited by
Tedelind, S., Westberg, F., Kjerrulf, M., & Vidal, A. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i20.2826 · Cited by 853
The Gut Microbiota and Alzheimer’s Disease
Jiang, C., Li, G., Huang, P., Liu, Z., & Zhao, B. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161141 · Cited by 852
Lin, P. W., & Stoll, B. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69525-1 · Cited by 848
Lu, H., Forbes, R. A., & Verma, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202487200 · Cited by 837
Gut microbiota-derived short-chain Fatty acids, T cells, and inflammation
Kim, C. H., Park, J., & Kim, M. (2014) · Immune Network · doi:10.4110/in.2014.14.6.277 · Cited by 704
Metadata
- Authors
- Yin, L., Laevsky, G., & Giardina, C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-11
- Volume
- 276
- Issue
- 48
- Pages
- 44641-44646
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2008431663
- Cited by
- 266
- References
- 78
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.